Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma

Kehua Zhou1, Christos Fountzilas2

  • 1Catholic Health System Internal Medicine Training Program, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA. kehuazho@buffalo.edu.

Cancers
|June 26, 2019
PubMed

Insights

New systemic treatments improve outcomes for advanced hepatocellular carcinoma (HCC), but managing unique toxicities alongside cirrhosis is crucial for maintaining patient quality of life and treatment efficacy.

Area of Science:

  • Hepatology and Oncology
  • Clinical Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) is a prevalent cancer often diagnosed at advanced stages with limited curative options.
  • Recent advancements include targeted therapies like kinase inhibitors (sorafenib, lenvatinib) and immunotherapies (nivolumab, pembrolizumab) for advanced HCC.
  • Cirrhosis, a common comorbidity, complicates treatment delivery and can exacerbate drug toxicities, impacting patient quality of life.

Purpose of the Study:

  • To review the efficacy and quality-of-life outcomes associated with modern systemic therapies for advanced HCC.
  • To provide clinicians with a reference for managing treatment-related toxicities in the context of cirrhosis.
  • To guide optimal management strategies balancing survival benefits and quality of life for advanced HCC patients.

Main Methods:

  • Systematic review of recent clinical trials and observational studies on systemic agents for advanced HCC.
  • Analysis of reported patient outcomes, including overall survival, progression-free survival, and quality-of-life metrics.
  • Evaluation of toxicity profiles and management strategies for common side effects, considering the impact of cirrhosis.

Main Results:

  • Modern systemic treatments have demonstrated improved long-term outcomes for patients with advanced HCC.
  • Treatment-related toxicities are common and can significantly affect patient quality of life, necessitating careful management.
  • Cirrhosis presents a significant challenge, potentially influencing drug efficacy and toxicity, and requiring tailored therapeutic approaches.

Conclusions:

  • Optimal management of advanced HCC requires a multidisciplinary approach, integrating modern systemic therapies with vigilant toxicity monitoring and cirrhosis management.
  • Balancing the benefits of novel agents with the risks of side effects is essential for preserving quality of life in patients with advanced HCC and cirrhosis.
  • Further research is needed to refine treatment strategies and supportive care for this complex patient population.

Related Concept Videos

Characteristics of Life01:23

Characteristics of Life

Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...
257.0K
Half-life of a Reaction02:42

Half-life of a Reaction

The half-life of a reaction (t1/2) is the time required for one-half of a given amount of reactant to be consumed. In each succeeding half-life, half of the remaining concentration of the reactant is consumed. For example, during the decomposition of hydrogen peroxide, during the first half-life (from 0.00 hours to 6.00 hours), the concentration of H2O2 decreases from 1.000 M to 0.500 M. During the second half-life (from 6.00 hours to 12.00 hours), the concentration decreases from 0.500 M to...
38.8K
The Tree of Life - Bacteria, Archaea, Eukaryotes02:40

The Tree of Life - Bacteria, Archaea, Eukaryotes

The “tree of life” describes the evolution of life and the evolutionary relationships between organisms. The root of the tree is the common ancestor to all life on Earth. All other species radiate from this point, much like the branches of a tree. The numerous tips of these branches on the tree of life represent every living, or extant, species. Extinct species, which are species that no longer exist, can be found towards the center of the tree. Currently, these organisms, both...
38.0K
The Angiosperm Life Cycle02:39

The Angiosperm Life Cycle

Plants have a life cycle split between two multicellular stages: a haploid stage—with cells containing one set of chromosomes—and a diploid stage—with cells containing two sets of chromosomes. The haploid stage is the gamete-producing gametophyte, and the diploid stage is the spore-producing sporophyte.
72.2K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.3K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
106.8K